MedPath

Prophylaxis of febrile neutropenia by reducing chemotherapy-induced gastrointestinal mucosal injury

Phase 3
Conditions
febrile neutropenia
Registration Number
JPRN-UMIN000011065
Lead Sponsor
Juntendo University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
75
Inclusion Criteria

Not provided

Exclusion Criteria

patients with underlying infection before developping neutropenia patients who is allergic to probiotics or glutamine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of febrile neutropenia
Secondary Outcome Measures
NameTimeMethod
severity of gastrointestinal mucosal injury stability of intestinal environments
© Copyright 2025. All Rights Reserved by MedPath